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Abstract 
Background: Acute kidney injury (AKI) is a known complication of malaria, and is reported to occur in up to 40 % of 
adult patients with a severe Plasmodium falciparum infection in endemic regions. To gain insight in the incidence and 
risk factors of AKI in imported P. falciparum malaria, a retrospective analysis was performed on a large cohort of mostly 
non-immune patients with imported P. falciparum malaria. Aiming to include not only severe but also milder forms of 
renal failure, the KDIGO criteria were used to define AKI.
Methods: Clinical and laboratory data from 485 consecutive cases of imported P. falciparum malaria were extracted 
from the Rotterdam Malaria Cohort database. Acute kidney injury (AKI) was defined using the KDIGO criteria. Univari-
ate and multivariate logistic regression analyses were used to identify risk factors for AKI.
Results: AKI was seen in 39 (8 %) of all patients and in 23 (38 %) of the 61 patients with severe malaria. Eight patients 
eventually needed renal replacement therapy (RRT); seven of them already had AKI at presentation. Higher age, 
higher leucocyte count and thrombocytopaenia were independently-associated with AKI but their positive predictive 
values were relatively poor.
Conclusion: AKI was found to be a common complication in adults with imported P. falciparum necessitating RRT in 
only a small minority of patients. The use of the KDIGO staging allows early recognition of a decline in renal function.
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Background
Acute kidney injury (AKI) is associated with a risk of 
chronic kidney disease and high mortality [1–3]. The 
clinical course of Plasmodium falciparum malaria may 
be complicated by AKI, contributing to the high mortal-
ity rate of severe malaria [4]. The pathogenesis of AKI in 
malaria is still not clearly understood. Blockage of renal 
microcirculation due to sequestration of infected eryth-
rocytes, immune-mediated glomerular injury and vol-
ume depletion are some of the proposed hypotheses [4, 
5]. The main histopathological finding in malaria-asso-
ciated AKI is acute tubular necrosis (ATN) with reports 
of interstitial nephritis and glomerulonephritis [4–7]. In 
malaria-endemic regions, AKI can occur in up to 40  % 
of adult patients with severe P. falciparum malaria, and 
it is associated with a mortality as high as 75  % when 
renal replacement therapy (RRT) is not started in time 
[8–11]. In non-immune travellers with severe P. falcipa-
rum infection, AKI is reported to occur in 34 to 52 % of 
cases [12–15]. In these studies, AKI is usually defined 
according to the WHO criteria for severe malaria, in 
which the creatinine threshold is preset at 265  μmol/L 
[13–15]. Using this relatively high threshold, less severe 
forms of renal failure are not taken into account. The 
present study, a retrospective analysis on a large cohort 
of patients with both severe and non-severe imported P. 
falciparum malaria, was designed to include these milder 
forms of renal failure in the analysis. To detect these, 
the criteria set by the Kidney Disease: Improving Global 
Outcomes (KDIGO) Acute Kidney Injury Work Group, 
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in which the dynamics of the GFR changes are taken into 
account, were used to define renal failure [16]. The study 
further aimed to determine which parameters are associ-
ated with the development of AKI.
Methods
Patients
The Harbour Hospital is a 161-bed general hospital, 
located in Rotterdam, The Netherlands. It also harbours 
the Institute for Tropical Diseases, which serves as a 
national referral centre. The Rotterdam Malaria Cohort 
consists of all patients diagnosed with malaria at the 
Institute for Tropical Diseases since 1998. Of all patients, 
anonymized demographic, clinical and laboratory data 
are routinely collected and stored in an electronic data-
base. For the present study, data from patients with 
imported P. falciparum malaria who entered the Rot-
terdam Malaria Cohort before January 1st, 2015 were 
analysed retrospectively. At that moment, the Rotter-
dam Malaria Cohort comprised 690 cases of imported 
malaria, of which 491 were caused by P. falciparum. Six 
cases were excluded because of missing creatinine values 
at initial presentation, leaving 485 patients for the analy-
sis. The six excluded cases had a favourable outcome and 
did not require RRT.
As this is a retrospective study of patient files, ethi-
cal approval was not necessary, as stated in the Medical 
Research involving Human Subjects Act (WMO).
Laboratory investigations
All laboratory data were measured on admission with 
routine procedures, as described before [17]. The stand-
ard procedure to diagnose malaria comprised a Quanti-
tative Buffy Coat (QBC) analysis, a rapid diagnostic test 
(RDT) for malaria antigens (Binax NOW® Malaria Test 
Binax, Inc. Maine, USA), and thick and thin blood smears 
using freshly collected blood specimens from finger 
pricks. The RDT and the QBC analysis were performed 
according to the manufacturer’s instructions. QBC cap-
illaries were examined independently by two technicians 
by microscopic analysis of two complete rows of the 
region between the bottom of the capillary and the poly-
nuclear leukocyte layer using an Olympus BX-60 fluores-
cence microscope equipped with UV-filter, 50× objective 
and 12.5× oculars (total magnification 625×).
Definitions
Acute kidney injury
Acute kidney injury (AKI) was defined using the KDIGO 
criteria, which include three stages of progressive renal 
dysfunction (see Additional file  1) [16]. Since patients 
may present with renal dysfunction without a known 
baseline serum creatinine, a classification based on a 
change of creatinine or estimated glomerular filtration 
rate (eGFR) from baseline poses a significant limita-
tion. To circumvent this problem, the following method, 
which was previously described as a suitable method by 
the ADQI Group [18], was used: in patients without pre-
viously measured creatinine levels, a normal premorbid 
renal function was assumed. A baseline creatinine level 
was then calculated, using the four-variable modification 
of diet in renal disease (MDRD) formula with an assumed 
normal eGFR. These calculated baseline values were used 
to estimate the change of renal function during infection 
(see Additional file 2).
Severe malaria
Patients were classified as having severe P. falciparum 
malaria if they met the recently updated World Health 
Organization (WHO) criteria for severe malaria on 
admission or during hospitalization (see Additional 
file 3) [19].
Immunity to malaria
Adult immigrants from a malaria-endemic country living 
in The Netherlands were considered partially immune, 
as they had likely been exposed to P. falciparum during 
childhood. Patients who had been born and raised and 
were still living in a malaria-endemic area at the time of 
diagnosis were presumed semi-immune. However, given 
the low number of semi-immune persons in the Rotter-
dam Malaria Cohort, they were grouped with partially 
immune individuals for the statistical analysis. All other 
patients were considered non-immune.
Statistical analysis
All data were extracted from the original database. For 
statistical analysis IBM Statistical Package for the Social 
Sciences (SPSS) version 22 (IBM Inc., Chicago, IL, USA) 
was used. Differences between the groups “AKI” and “no 
AKI” were analysed using Fisher’s exact test or Chi square 
test for nominal variables. For continuous variables the 
unpaired two sample t test or the Mann–Whitney U 
test was used. Normality of distribution of variables was 
tested with the Kolmogorov–Smirnov test. Univariate 
and multivariate logistic regression analyses were used 
to identify risk factors for AKI in malaria at initial pres-
entation. Based on the univariate analysis, variables with 
a P value <0.10 were included in the multivariate logis-
tic regression. The details of the univariate and multi-
variate regression analysis are available as supplementary 
files (see Additional files 4 and 5). For the variables that 
were significant in the multivariate analysis, the diag-
nostic performance for detecting KDIGO-defined AKI 
was evaluated, using the odds ratio, sensitivity, specific-
ity, negative and positive predictive value at the optimal 
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cut off point (determined using the Youden’s index) and 
the area under the receiver operating characteristics 
curve (AUROC). All reported P values are two-tailed, 
and P values less than 0.05 were considered statistically 
significant.
Results
Patient characteristics and incidence of AKI
The general characteristics on admission of the 485 
included patients are shown in Table 1. Fifty-nine patients 
were treated as outpatient or finished their treatment at 
home, all other patients were treated as inpatients. None 
of the patients had serum creatinine levels measured in 
The Harbour Hospital prior to admission; the premorbid 
creatinine levels were, therefore, calculated according to 
the described method to subsequently apply the KDIGO 
classification. AKI, defined as a KDIGO stage 1, 2 or 3, 
was seen in 39 (8 %) of all 485 patients with imported fal-
ciparum malaria and in 23 (38 %) of the 61 patients with 
severe malaria. Immunity differed significantly between 
the groups with and without AKI, with non-immunes 
being over-represented in the AKI group. The use of 
potentially nephrotoxic co-medication (non-steroidal 
anti-inflammatory drugs (NSAIDs), ACE-inhibitors, 
diuretics or lithium) did not differ significantly between 
groups. Pulse rate was significantly higher in the AKI 
group and the systolic blood pressure was significantly 
lower in comparison to patients without AKI. Apart from 
creatinine and urea, also leukocytes, C-reactive protein 
(CRP), creatinine, total bilirubin, lactate, lactate dehy-
drogenase (LDH), alanine transaminase (ALAT), aspar-
tate transaminase (ASAT) and parasite load levels were 
all significantly higher in the AKI group, while thrombo-
cytes and serum sodium levels were significantly lower. 
There was no significant difference in the number of 
patients with circulatory shock between the two groups 
(three in the AKI group versus 13 in the no-AKI group. 
Severe malaria was significantly more common in the 
AKI group, as might be anticipated since AKI is one of 
the defining criteria for severe malaria (see Additional 
file 3). There were two deaths, both in the AKI group.
On admission, a concomitant infection was suspected 
in 64 patients and proven in 31 patients. Fourteen of 
these concerned a bacterial infection, of which five were 
in the AKI group (two with a pneumonia and three with 
an urinary tract infection). One of these had a positive 
blood culture with an Escherichia coli. All other blood 
cultures remained negative.
Deterioration of kidney function during admission
In 27 (69  %) of the 39 patients with AKI, kidney injury 
was already present at presentation; in the other twelve 
Table 1 General characteristics on admission
AKI
n = 39
No AKI
n = 446
P value
Demographic findings
Age (years) 47 (26–70) 39 (4–78) <0.001
Male gender 27 (69) 325 (73) 0.708
Ethnicity 0.078
 Caucasian 24 (62) 189 (42) 0.028
 African 11 (28) 218 (49) 0.018
 Asian 2 (5) 14 (3) 0.374
 Other 2 (5) 22 (5) 1.000
Adequate prophylaxis 
use
0 (0) 42 (9) 0.052
Symptoms ≥8 days 16 (41) 111 (25) 0.055
Immunity 0.038
 Non-immune 28 (74) 218 (53) 0.007
 Partially immune 10 (26) 188 (45) 0.060
 Semi-immune 0 (0) 9 (2) 1.000
Nephrotoxic  
co-medication*
5 (20) 24 (5) 0.073
Clinical findings
Temperature (°C) 38.5 (1.3) 38.4 (1.3) 0.852^
Systolic blood pressure 
(mmHg)
114 (21.3) 123 (18.3) 0.017^
Pulse rate (beats/min) 104 (20.1) 94 (17.3) 0.003^
Glasgow Coma Scale 15 (5–15) 15 (9–15) <0.001
Laboratory findings
Haemoglobin (mmol/L) 8.1 (1.8) 8.3 (1.3) 0.929^
Leucocytes (×109/L) 7.5 (3.2) 5.2 (2.0) <0.001^
Thrombocytes (×109/L) 29 (2–188) 91(3–385) <0.001
CRP (mg/L) 185 (16–476) 91 (1–363) <0.001
Creatinine (µmol/L) 166 (77–1081) 93 (39–175) <0.001
Urea (mmol/L) 13.8 (4.1–55.8) 5.0 (1.5–33.6) <0.001
Sodium (mmol/L) 131 (6.2) 135 (4.0) <0.001^
Potassium (mmol/L) 3.7 (0.6) 3.8 (0.4) 0.422^
Bilirubin total (µmol/L) 52 (10–416) 22 (3–304) <0.001
ASAT (U/L) 96 (9–394) 32 (9–326) <0.001
ALAT (U/L) 68 (12–655) 36 (3–265) <0.001
LDH (U/L) 488 (127–2297) 268 (103–1833) <0.001
Lactate (mmol/L) 3.0 (1.0–6.2) 1.4 (0–5.5) <0.001
Parasitaemia  
(parasites/µL)
128,000 (240–
1,380,600)
8400 (2–784,000) <0.001
Concomitant bacterial 
infection
5 (13) 9 (2) 0.003
Treatment <0.001
 Quinine iv 19 (49) 54 (12) <0.001
 Artesunate iv 13 (33) 27 (6) <0.001
 Atovaquone/proguanil 4 (10) 279 (63) <0.001
 Halofantrine 1 (3) 54 (12) 0.108
 Artemether/ 
lumefantrine
0 (0) 4 (1) 1.000
 Unknown 2 (5) 28 (6) 1.000
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the initial KDIGO stage was 0. A deterioration of kid-
ney function, defined as a progression of KDIGO stage 
during admission, was seen in 17 (44  %) of the 39 AKI 
patients. Eight patients eventually needed RRT; one of 
these patients had a normal renal function at initial pres-
entation (Table  2). The maximal creatinine level was 
reached after a median of 0.3 days (range 0–3.4 days) in 
non-RRT patients. In the 8 RRT patients, creatinine lev-
els rose maximally with 414  μmol (median 209  μmol) 
after a median of 1.3 days (range 0–3.4 days) before they 
were referred for dialysis.
KDIGO stage versus WHO defined malarial AKI
The 2014 WHO definition for renal failure, as a criteria 
for severe malaria, uses the serum creatinine level at a 
cut-off of 265  μmol/L. At initial presentation, this crit-
erium was met by 19 of the 485 patients (4  %) or 31  % 
of patients with WHO defined severe malaria (19/61). 
Among these 19 patients are five of the eight patients 
(63  %) that eventually needed RRT. Using the KDIGO 
classification, seven of these eight patients (89 %) would 
have been identified; two classified as stage 2 and five as 
stage 3 at presentation.
Predictors for the outcome AKI
The receiver operating characteristics (ROC) curves of 
the evaluated variables are available as an Additional 
file  6: Figure S1. Multivariate logistic regression analy-
sis revealed that age, leucocytes and thrombocytes were 
independently associated with AKI. However, they all 
had relatively poor positive predictive values for AKI 
despite acceptable negative predictive values (Table  3). 
Creatinine and urea were not entered in the multivari-
ate analysis, as they belong to the defining criteria for 
AKI.
Characteristics and outcome patients needing RRT
Eight patients were referred for RRT. Their median age 
was 52.5 (range 36–62) and 3 (38  %) were female. Half 
of the patients were non-immune and half partially 
immune. All were admitted in the ICU and received 
intravenous treatment. Indications for dialysis were 
acidosis (4/8 patients), uremia (2/8 patients) and fluid 
overload (2/8 patients). None of the patients was hyper-
kalemic. All patients met more than one of the WHO 
severity criteria during admission; two met two criteria, 
one three, two four, one five and two met nine severity 
criteria.
In five of the eight RRT patients (63 %) renal function 
recovered fully during admission, but two patients pro-
gressed to end-stage renal disease (ESRD). In one of them 
the renal biopsy showed severe ischemic changes and a 
tubulo-interstitial nephritis with advanced scarring. She 
switched from haemodialysis to peritoneal dialysis and 
eventually received a renal transplantation. In the other 
patient with ESRD the renal biopsy remarkably showed 
a collapsing glomerulopahy, for which other causes were 
excluded. She is currently still on haemodialysis and 
is being prepared for a transplantation. Her case was 
described in detail previously [20]. One patient died of 
a suspected central pulmonary embolism 2  weeks after 
admission, while still on intermittent haemodialysis for 
the malaria-induced AKI.
P values <0.05 are considered significant
* Self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs), ACE-
inhibitors, diuretics or lithium
^ Normally distributed continuous variables, given as mean (SD) with P values 
derived from t tests. All other continuous variables are not normally distributed 
and given as median (range) with P values derived from Mann–Whitney U tests. 
Nominal variables are given as number (percentage)
Table 1 continued
AKI
n = 39
No AKI
n = 446
P value
Outcome
 Severe malaria  
(WHO 2014)
29 (74) 32 (11) <0.001
 Renal replacement 
therapy
8 (21) 0 (0) <0.001
 Death 2 (5) 0 (0) 0.006
Table 2 KDIGO score at  initial presentation in  relation 
to worst score during admission
Worst KDIGO stage
0 1 2 3 Total
Initial KDIGO stage
0 446 8 2 2 458
1 9 3 0 12
2 6 2 8
3 7 7
Total 446 17 11 11 485
Table 3 Diagnostic performance of variables that are inde-
pendently associated with AKI
Variable Age Thrombocytes Leukocytes Creatinine
P value 0.002 0.005 0.005 Reference
Cut-off >43 years ≤32 × 109/L >6.1 × 109/L 120 µmol/L
Sensitivity 70 (54–83) 62 (45–77) 62 (45–77) 85 (70–94)
Specificity 63 (59–68) 93 (90–95) 74 (70–78) 92 (89–94)
PPV 15 (10–20) 43 (30–57) 17 (11–24) 48 (36–60)
NPV 96 (93–98) 97 (94–98) 96 (93–98) 99 (97–100)
AUROC 0.69  
(0.65–0.73)
0.80  
(0.77–0.84)
0.73  
(0.69–0.77)
0.90  
(0.88–0.93)
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Discussion
AKI is a frequently observed complication of malaria in 
adults, both in malaria-endemic countries and in non-
endemic regions [5–15]. The overall prevalence of AKI, 
defined according to the KDIGO classification, in the 
Rotterdam Malaria Cohort was 8 % in all patients with P. 
falciparum infection and 38 % in patients with severe dis-
ease. Age, leucocytes and thrombocytes were found to be 
independently associated with AKI.
Some authors report AKI incidence rates as high as 
52.5  % in patients with imported malaria [15] whereas 
others found incidences as low as 1 % [21–23]. There are 
several explanations for this large variation. Most impor-
tantly, different definitions of AKI have been used. Many 
studies on malaria in endemic regions use the WHO 
criteria for severe malaria, where the serum creatinine 
threshold for AKI is preset at 265  μmol/L. Other stud-
ies have used the RIFLE (acronym for risk, injury, failure, 
loss of renal function and end stage renal disease) staging 
[23, 24]. In the current study the KDIGO criteria were 
used. The optimal serum creatinine threshold for the 
detection of AKI, defined as a KDIGO stage 1 or higher, 
was found to be 120 μmol/L, which is much lower than 
the threshold used in the WHO criteria. The current con-
sensus is to define AKI according to the KDIGO criteria.
Variation in incidence rates can also be explained by 
differences in the patient populations that are analysed. 
Many studies have reported the incidence of AKI in 
cohorts of patients with P. falciparum only [10, 11, 12, 
13, 14, 21, 24], while some used cohorts with malaria 
caused by any Plasmodium species [22, 23, 25, 26], and 
several studies report on specific subsets of patients like 
patients with WHO defined severe P. falciparum infec-
tion [10, 12, 13, 14, 24]. The immune status of the patient 
may also influence the risk of AKI. In previous studies it 
was shown that non-immune individuals with imported 
P. falciparum malaria have a higher risk of severe malaria 
and its complications including AKI, than partially- or 
semi-immune subjects [5, 6, 11, 27]. In the present study, 
non-immune patients were overrepresented in the AKI 
group.
It was previously shown that in AKI in severe malaria 
a return to baseline creatinine occurs after 17 ±  6  days 
[10]. Most patients with AKI do not require RRT and 
a return to baseline kidney function is achieved in the 
vast majority of patients in response to anti-malarial 
therapy and fluid resuscitation alone [5, 10, 28]. In line 
with these observations, only eight patients of the Rotter-
dam Malaria Cohort needed RRT, and five of these eight 
patients had a full recovery of their renal function during 
admission. However, the long-term prognosis of recov-
ered AKI patients has been a matter of debate. A meta-
analysis of Coca et al. [1] showed that patients with AKI 
are more likely to develop chronic kidney disease later 
on (CKD). As three of the eight RRT patients in the Rot-
terdam Malaria Cohort were not residents of the Nether-
lands and returned to their home countries not long after 
being discharged, information about whether or not their 
recovered renal functions remained stable in the long 
term is not available.
The most important limitation of this study is that, 
in the absence of data on premorbid creatinine levels, 
assumptions had to be made about the baseline kid-
ney function of the included patients. Although these 
assumptions might be wrong in individual cases, there 
is no obvious reason to assume that the baseline kidney 
functions of the patients in this cohort, which consists 
mostly of international travellers with little comorbid-
ity, are in general any different from the reference val-
ues. The method has been proposed as a suitable option 
in case of missing baseline renal function by the Acute 
Dialysis Quality Initiative (ADQI) Group and has been 
used before in similar studies [18, 29]. Still, the pos-
sibility remains that AKI was over-diagnosed, as some 
patients may have had some form of chronic kidney dis-
ease before admission with malaria. Also, information 
about comorbidity was absent for some patients in the 
database. The presence of comorbid risk factors might 
have contributed to the development of AKI in some 
patients. Another limitation is that follow-up creatinine 
levels were not available in the majority of patients who 
had a normal admission creatinine. It cannot be excluded 
that some of these patients developed AKI later on, but, 
as this concerns patients with mild disease who were dis-
charged after a short admission, AKI is not likely to be a 
common complication in this group.
If AKI is detected early, measures can be taken to pre-
vent further deterioration of kidney function and the 
development of associated complications. These meas-
ures include timely institution of proper parenteral 
anti-malarial treatment, fluid replacement, avoidance of 
nephrotoxic drugs and, if indicated, RRT [5, 9, 10, 28]. 
The use of the KDIGO classification allows for an early 
detection of changes in GFR, but nevertheless 12 of 39 
AKI (31  %) patients in the Rotterdam Malaria Cohort 
had no evidence of kidney injury at first presentation. 
This observation emphasizes that the use of serum cre-
atinine-based prediction models for AKI has limitations. 
In several animal model studies it has been shown that 
functional injury of the kidney, reflected in serum creati-
nine values, is preceded by structural injury [30]. Predic-
tion of AKI in malaria could theoretically become more 
accurate with the use of markers of structural kidney 
injury, such as the novel biomarkers Neutrophil Gelati-
nase-Associated Lipocalin (NGAL) and Kidney Injury 
Molecule-1 (KIM-1). Recent studies, performed in a 
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broad range of experimental and clinical settings includ-
ing cardiac surgery, kidney transplantation, contrast-
induced AKI and critically ill patients, show that the use 
of these markers may improve risk assessment [30–35]. 
A study in adult malaria patients in Bangladesh showed 
that NGAL was not superior to creatinine to predict the 
requirement of RRT, but patients in this study generally 
presented severely ill and more than half of them already 
had a decreased eGFR at admission [36]. One could spec-
ulate that findings in imported malaria, where patients 
usually tend to present much earlier in the course of the 
infection, could be different.
Conclusion
Acute kidney injury is a common complication in adults 
with imported P. falciparum infection, occurring in 8 % 
of cases and in 38 % of the patients with severe malaria. 
RRT was necessary in eight of the 39 patients with AKI. 
The use of the KDIGO staging allows an earlier recogni-
tion of a decline in renal function in imported malaria 
as compared to the WHO criteria, but more research is 
needed to determine whether novel biomarkers can help 
to detect AKI in an earlier stage.
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